

Cover Story
SWOG earlier this week started to accrue patients to Lung-MAP, a clinical trial for second-line treatment of non-small cell lung cancer.
By Tessa Vellek
In Brief


Trending Stories
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- The Susan Wojcicki Foundation pushes for rethinking of strategies for early lung cancer detection
- Vermont researchers discover transmissible cancer in catfish—first ever in a freshwater animal
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Patricio Polanco named chief of surgical oncology and surgeon-in-chief at Atrium Health Levine Cancer










